pills split into two

Our guidance and advice to help manage common infections and tackle antimicrobial resistance.

We've been asked by the Department of Health to develop evidence-based, clinical syndrome specific guidance and advice to help slow the development of antimicrobial resistances.

Guidance

Our guidelines offer evidence-based antimicrobial prescribing information for all care settings.

They focus on bacterial infections and appropriate antibiotic use. Each guideline topic features a  of the recommendations, a guideline and an evidence review.

The visual summary is an overview of the guideline recommendations. It includes a prescribing table to support shared antimicrobial prescribing decisions in line with a health professional’s own clinical judgement.

An example of the draft visual summary for our sinusitis guideline:

summary of our recommendations on sinusitis   summary of our recommendations on sinusitis

Sinusitis (acute)

summary of our recommendations on sinusitis

Publishing: 31 October 2017


Advice

Our antimicrobial evidence summaries provide commissioners, providers and health professionals with a summary of the best available evidence for antimicrobials. 


In development

We are currently developing guideline recommendations on the following topics:


Why is our guidance and advice needed?

The World Health Organization states that 'antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective'.

Resistance to antimicrobials is complex and increasing. Combined with a lack of new antimicrobial medicines, there is a growing risk that infections may not be treatable in the future. 

The Department of Health asked us to develop guidelines to help slow antimicrobial resistance. These guidelines are evidence-based and clinical syndrome specific. 

Read more about the importance of antimicrobial resistance at Health matters: antimicrobial resistance.

When we as health professionals are discussing treatments for common infections with patients, it is important to talk about the benefits and harms of prescribing antibiotics, including the risks of antimicrobial resistance and the threat this poses to public healthTessa Lewis, GP and Chair of the managing common infections advisory committee
photograph of Tessa Lewis


How we develop guidance and advice

Antimicrobial prescribing guidelines

Find out how we develop antimicrobial prescribing guidance in the:

The scope sets out the remit for the programme:

Evidence summaries

Find out how we develop our advice in the:

 

Get involved


Antimicrobial news at NICE

pills on the floor - 200x200

Antibiotic resistance is now 'common' in urinary tract infections

The number of urinary tract infections (UTIs) caused by drug resistant bacteria is increasing, new data shows.

Read article

Most common ear infections should not be treated with antibiotics, says NICE

Antibiotics should not be used to treat the majority of sinus infections

We're advising healthcare professionals to tell their patients that a sinus infection will likely clear-up without antibiotics.

Read article